Inventors:
Sean P. Colgan - Foxfield CO, US
Jonathan Goldstein - Pittsford NY, US
International Classification:
C40B 30/04, G01N 33/53, G01N 33/566, C12Q 1/68
US Classification:
506 9, 435 612, 435 71, 435 792, 435 794, 436501
Abstract:
The present invention provides methods for using granulocyte macrophage colony-stimulating factor receptor (CD116) expression level for various clinical applications including, but not limited to, diagnosing inflammatory bowel disease in a subject.